Javascript must be enabled to continue!
Portal Vein Thrombosis in a Patient with Type 1 Diabetes Presenting as Acute Pyelonephritis
View through CrossRef
Background: Few cases have been reported with respect to portal vein thrombosis in non-cirrhotic patients. Asymptomatic or non-specific symptoms of portal vein thrombosis may lead to misdiagnosis or may delay the diagnosis until complications develop. We report a case of portal vein thrombosis in a patient with type 1 diabetes presenting as acute pyelonephritis. Case description: An 18-year-old female with type 1 diabetes on an insulin pump presented with epigastric abdominal pain for 3 days associated with nausea and vomiting. She was a conscious, alert, young female who appeared to be in pain. Vital signs were stable with a random blood sugar (RBS) level of 179 mg/dl. Abdominal examination revealed a soft and lax abdomen with tenderness in the epigastric area and right renal angle, as well as no sign of rigidity or rebound tenderness. No signs of ascites, splenomegaly or hepatomegaly were noted. Investigations showed a WBC count of 10.2, neutrophils at 65%, urine microsopy analysis revealed WBCs between 30–50 per high power field, with culture showing >105 CFU/ml. All parameters of a thrombophilic screen were within normal values. Computed tomography (CT) revealed reduced enhancement of the right kidney, likely indicating acute pyelonephritis, and left portal vein oedema with complete occlusion. Local factors and prothrombotic disorders were ruled out. The patient was managed with ciprofloxacin, enoxaparin and warfarin. Follow-up imaging revealed complete resolution of thrombosis. Conclusions:Portal vein thrombosis is an uncommon condition in the absence of liver disease. Few case reports exhibit sepsis and portal vein thrombosis. Sepsis can create a predisposed environment for hypercoagulability. To our knowledge, this is the first case report of pyelonephritis with portal vein thrombosis.
Title: Portal Vein Thrombosis in a Patient with Type 1 Diabetes Presenting as Acute Pyelonephritis
Description:
Background: Few cases have been reported with respect to portal vein thrombosis in non-cirrhotic patients.
Asymptomatic or non-specific symptoms of portal vein thrombosis may lead to misdiagnosis or may delay the diagnosis until complications develop.
We report a case of portal vein thrombosis in a patient with type 1 diabetes presenting as acute pyelonephritis.
Case description: An 18-year-old female with type 1 diabetes on an insulin pump presented with epigastric abdominal pain for 3 days associated with nausea and vomiting.
She was a conscious, alert, young female who appeared to be in pain.
Vital signs were stable with a random blood sugar (RBS) level of 179 mg/dl.
Abdominal examination revealed a soft and lax abdomen with tenderness in the epigastric area and right renal angle, as well as no sign of rigidity or rebound tenderness.
No signs of ascites, splenomegaly or hepatomegaly were noted.
Investigations showed a WBC count of 10.
2, neutrophils at 65%, urine microsopy analysis revealed WBCs between 30–50 per high power field, with culture showing >105 CFU/ml.
All parameters of a thrombophilic screen were within normal values.
Computed tomography (CT) revealed reduced enhancement of the right kidney, likely indicating acute pyelonephritis, and left portal vein oedema with complete occlusion.
Local factors and prothrombotic disorders were ruled out.
The patient was managed with ciprofloxacin, enoxaparin and warfarin.
Follow-up imaging revealed complete resolution of thrombosis.
Conclusions:Portal vein thrombosis is an uncommon condition in the absence of liver disease.
Few case reports exhibit sepsis and portal vein thrombosis.
Sepsis can create a predisposed environment for hypercoagulability.
To our knowledge, this is the first case report of pyelonephritis with portal vein thrombosis.
Related Results
The Prevalence of JAK2 Mutation in High-Altitude Patients with Unprovoked Thrombosis and Thrombosis at Unusual Sites
The Prevalence of JAK2 Mutation in High-Altitude Patients with Unprovoked Thrombosis and Thrombosis at Unusual Sites
Introduction
Thrombosis, both arterial and venous, is a major source of morbidity and mortality in patients with myeloproliferative neoplasms (MPNs). Thrombosis can ...
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
Background Many cardiovascular conditions exhibit seasonality in occurrence and mortality, but little is known about the seasonality of venous thromboembolism.
Methods ...
To Compare the Kidney Dimensions in Healthy Individuals with Acute and Chronic Pyelonephritis Patients Using CT Scan as an Imaging Modality
To Compare the Kidney Dimensions in Healthy Individuals with Acute and Chronic Pyelonephritis Patients Using CT Scan as an Imaging Modality
Acute or chronic pyelonephritis is a common renal pathology that can lead to significant kidney morphological changes. Accurate assessment of renal dimensions using imaging modalit...
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Undiagnosed Diabetes in Acute Coronary Syndrome: A Silent Threat in Pakistan
Diabetes mellitus (DM) has emerged as one of the most pressing public health challenges globally, and Pakistan stands among the countries most severely affected. With rising urbani...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?
Non-Cirrhotic Splanchnic Vein Thrombosis: When Is Anticoagulation Enough?
Abstract
Abstract 3390
Background:
In the absence of primary liver disease, thrombosis of the splanchnic vessels ...
Frequency of Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma
Frequency of Portal Vein Thrombosis in Patients with Hepatocellular Carcinoma
The hepatocellular carcinoma (HCC) is a frequent complication of liver. Portal vein thrombosis is common in HCC patients and associated with poor prognosis. But evidence lacks for ...
A Rare Case of Portal Vein Thrombosis due to Protein S deficiency in a patient with Decompensated Cryptogenic CLD with Portal Hypertension, Completely Recanalized by Single Oral Anticoagulant-Rivaroxaban
A Rare Case of Portal Vein Thrombosis due to Protein S deficiency in a patient with Decompensated Cryptogenic CLD with Portal Hypertension, Completely Recanalized by Single Oral Anticoagulant-Rivaroxaban
Venous thromboembolic diseases are a group of heterogeneous diseases with different clinical forms and prognosis. Abdominal venous thrombosis may present either as Budd-Chiari synd...

